These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6173164)

  • 1. Optical transforms of phleomycin-induced nodules in DNA.
    Pietsch P
    Cytobios; 1981; 31(123-124):143-9. PubMed ID: 6173164
    [No Abstract]   [Full Text] [Related]  

  • 2. Phleomycin and bleomycin resistance in Escherichia coli.
    Grigg GW; Collis CM
    J Antibiot (Tokyo); 1989 Mar; 42(3):482-5. PubMed ID: 2468633
    [No Abstract]   [Full Text] [Related]  

  • 3. Amplifications of phleomycin and bleomycin-induced antibiotic activity in Escherichia coli by aromatic cationic compounds.
    Grigg GW; Gero AM; Hughes JM; Sasse WH; Bliese M; Hart NK; Johansen O; Kissane P
    J Antibiot (Tokyo); 1977 Oct; 30(10):870-8. PubMed ID: 73539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Differences in sensitivity of T3, T7, T4 and lambda phages to bleomycin and phleomycin].
    Scholz D; Meissner C; Rosenthal HA
    Z Allg Mikrobiol; 1979; 19(10):745-52. PubMed ID: 94958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of sensitivity to phleomycin in growing Escherichia coli cells.
    Sleigh MJ; Grigg GW
    Biochem J; 1976 Apr; 155(1):87-99. PubMed ID: 59594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage of cellular and extracellular Saccharomyces cerevisiae DNA by bleomycin and phleomycin.
    Moore CW
    Cancer Res; 1989 Dec; 49(24 Pt 1):6935-40. PubMed ID: 2479473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Escherichia coli mutant resistant to phleomycin, bleomycin, and heat inactivation is defective in ubiquinone synthesis.
    Collis CM; Grigg GW
    J Bacteriol; 1989 Sep; 171(9):4792-8. PubMed ID: 2475481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition and enhancement of phleomycin-induced DNA breakdown by aromatic tricyclic compounds.
    Grigg GW; Gero AM; Sasse WH; Sleigh MJ
    Nucleic Acids Res; 1984 Dec; 12(23):9083-93. PubMed ID: 6083550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internucleosomal cleavage and chromosomal degradation by bleomycin and phleomycin in yeast.
    Moore CW
    Cancer Res; 1988 Dec; 48(23):6837-43. PubMed ID: 2460230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and mapping of regions of the plasmid pKM101 which influence the growth rate and resistance to phleomycin E of Escherichia coli WP2.
    Hall RM
    J Bacteriol; 1985 Sep; 163(3):1142-6. PubMed ID: 2411715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a Tn5 determinant conferring resistance to phleomycins, bleomycins, and tallysomycins.
    Collis CM; Hall RM
    Plasmid; 1985 Sep; 14(2):143-51. PubMed ID: 2415995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phleomycin resistance encoded by the ble gene from transposon Tn 5 as a dominant selectable marker in Saccharomyces cerevisiae.
    Gatignol A; Baron M; Tiraby G
    Mol Gen Genet; 1987 May; 207(2-3):342-8. PubMed ID: 2441230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An autonomously replicating plasmid transforms Botrytis cinerea to phleomycin resistance.
    Santos M; Vallejo I; Rebordinos L; Gutiérrez S; Collado IG; Cantoral JM
    FEMS Microbiol Lett; 1996 Apr; 137(2-3):153-8. PubMed ID: 8998978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phleomycin-induced DNA lesions and their repair in Escherichia coli K12.
    Nakayama H
    Basic Life Sci; 1975; 5B():483-85. PubMed ID: 1103864
    [No Abstract]   [Full Text] [Related]  

  • 15. Sulphydryl-mediated DNA breakage by phlemomycin in Escherichia coli.
    Sleigh MJ; Grigg GW
    Mutat Res; 1977 Feb; 42(2):181-90. PubMed ID: 320461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification of the antibiotic effects of the bleomycins, phleomycins and tallysomycins: its dependence on the nature of the variable basic groups.
    Grigg GW; Hall RM; Hart NK; Kavulak DR; Lamberton JA; Lane A
    J Antibiot (Tokyo); 1985 Jan; 38(1):99-110. PubMed ID: 2579055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of in vivo (cellular) phleomycin sensitivity by nuclear genotype, growth phase, and metal ions.
    Moore CW
    Cancer Res; 1982 Mar; 42(3):929-33. PubMed ID: 6174219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of phleomycin-induced DNA damage on the fission yeast Schizosaccharomyces pombe cell cycle.
    Belenguer P; Oustrin ML; Tiraby G; Ducommun B
    Yeast; 1995 Mar; 11(3):225-31. PubMed ID: 7785323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of deoxyribonucleic acid cleavage by bleomycin, phleomycin, and tallysomycin.
    Kross J; Henner WD; Hecht SM; Haseltine WA
    Biochemistry; 1982 Aug; 21(18):4310-8. PubMed ID: 6181807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phleomycin resistance as a dominant selectable marker in CHO cells.
    Mulsant P; Gatignol A; Dalens M; Tiraby G
    Somat Cell Mol Genet; 1988 May; 14(3):243-52. PubMed ID: 2453083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.